Quick Facts at a Glance
- Recall Date
- December 15, 2025
- Hazard Level
- HIGH
- Brands
- GLYCOPYRROLATE, Novadoz Pharmaceuticals LLC
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- GLYCOPYRROLATE, Novadoz Pharmaceuticals LLC
- Product type
- Glycopyrrolate Oral Solution
- Model numbers
- Lot # CB2505159A, CB2505160A, Exp Date: 04/2027, Lot # CB2505161A, Exp Date: 05/2027
- UPC codes
- 72205-070, 72205-070-72
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
December 15, 2025
Reported by FDA DRUG
February 4, 2026
RecallRadar source check
February 11, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Failed Impurities/Degradation Specifications
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact NOVADOZ PHARMACEUTICALS LLC or your healthcare provider for guidance. Notification method: Letter
About This Product
Glycopyrrolate Oral Solution is used to treat various medical conditions by reducing secretions. Patients typically use it for gastrointestinal issues or as part of anesthesia protocols.
Why This Is Dangerous
The product's failure to meet impurities and degradation specifications indicates potential contamination or instability, which can compromise its effectiveness and safety.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face health risks if they continue using this medication. The recall emphasizes the importance of monitoring pharmaceutical products for safety.
Practical Guidance
How to identify if yours is affected
- Check the lot number on the product label.
- Verify if your product matches the recalled lot numbers: CB2505159A, CB2505160A, CB2505161A.
- Look for the expiration dates: April 2027 and May 2027.
Where to find product info
Lot numbers and expiration dates can usually be found on the label or packaging of the product.
What timeline to expect
Expect a refund or guidance within 4-6 weeks after contacting the manufacturer.
If the manufacturer is unresponsive
- Follow up with Novadoz Pharmaceuticals LLC via email or phone.
- Contact the FDA to report unresponsiveness.
How to prevent similar issues
- Always check for recalls on medications before purchase.
- Consult with your healthcare provider about alternative medications.
- Review product packaging for safety certifications.
Documentation advice
Keep a record of your purchase receipt, correspondence with the manufacturer, and any notes regarding your health status.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recalled Glycopyrrolate Oral Solution has the NDC 72205-070-72. It comes in a 16 oz. (473 mL) bottle. Specific lot numbers include CB2505159A, CB2505160A, and CB2505161A, with expiration dates of April 2027 and May 2027.
Key Facts
- Recall date: December 15, 2025
- Report date: February 4, 2026
- Dosage form: Oral solution
- Risk level: High
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
